Proteolysis-focusing on chimeras (PROTACs) and molecular glue degraders (MGDs) are one of the most maturely designed TPD techniques. On this critique, we focus on equally preclinical experiments and clinical trials to offer a comprehensive summary of the protection and medical performance of PROTACs and MGDs in hematologic malignancies in the https://carolinei308agl2.theisblog.com/profile